| Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia M Solaymani-Dodaran, M Ghanei, M Bagheri, A Qazvini, E Vahedi, ... International immunopharmacology 95, 107522, 2021 | 80 | 2021 |
| The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial M Ghanei, M Solaymani-Dodaran, A Qazvini, AH Ghazale, ... Respiratory Research 22, 1-14, 2021 | 36 | 2021 |
| Phase II, safety and immunogenicity of RAZI Cov Pars (RCP) SARS Cov-2 vaccine in adults aged 18–70 years; a randomized, double-blind clinical trial A Mohazzab, MHF Mehrabadi, A Es-Haghi, S Kalantari, L Mokhberalsafa, ... Journal of Pharmaceutical Sciences 112 (12), 3012-3021, 2023 | 9 | 2023 |
| Immunogenicity and safety of a combined intramuscular/intranasal recombinant spike protein COVID-19 vaccine (RCP) in healthy adults aged 18 to 55 years old: a randomized … MS Dodaran, SR Banihashemi, A Es-Haghi, MHF Mehrabadi, M Nofeli, ... Vaccines 11 (2), 455, 2023 | 6 | 2023 |
| Validity & Reliability Assessment of Persian Version of Core Section of the Behavioral Risk Factor Surveillance System (BRFSS) Questionnaire A Ansarifar, H Soori, BA AKBARZADEH, M Movaheddi Iranian Journal of Epidemiology 9 (1), 1-10, 2013 | 6 | 2013 |
| Factors affecting the satisfaction of Healthcare Workers with the Healthcare System Reform Plan in Healthcare Networks in Bushehr Province in 2018: a qualitative study Z Allahyari, A KHodami, A Farhadi, R Hajiyoni, A AnsariFar, M Marzban Iranian South Medical Journal 23 (5), 475-493, 2020 | 5 | 2020 |
| Inequality in distribution of general physicians in primary health care in Bushehr, Iran (2010-2013) R Honarmand, M Yandarani, H Doosti, M Mansurian, A Niknam Payesh (Health Monitor) 15 (5), 515-522, 2016 | 5 | 2016 |
| The Relationship between Occupational Stress & Related Injuries among Physician’s Assistants: A Case-Control Study S Mahfoozpour, FK Shadmani, A Ansarifar ارتقای ایمنی و پیشگیری از مصدومیت ها 1 (4), 222-227, 2014 | 5 | 2014 |
| Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18–70 years F Gholami, R Hamidi Farahani, A Karimi Rahjerdi, M Ahi, A Sheidaei, ... BMC Infectious Diseases 23 (1), 118, 2023 | 4 | 2023 |
| Lifestyle and hypertension in rural population of Tangestan town, Iran M Yandarani, M Mansourian, A Ansarifar, F Mohamadi, O Safari, J Yousefi, ... Chronic Diseases Journal, 226-232, 2019 | 4 | 2019 |
| Geographic distribution and time trends of water-pipe use among Iranian youth and teenage students: a meta-analysis and systematic review S Afrashteh, A Ansarifar, M Vali, L Nami Nazari, N Keshtkar, S Memar, ... Journal of Ethnicity in Substance Abuse 22 (2), 285-315, 2023 | 3 | 2023 |
| Codon 72 Polymorphism of TP53 Gene in Cervical Biopsies with Abnormal Histology in Bushehr Province M Zaker Hosseini, S Naeimi, M Moradinasab, S Taherkhani, ... Iranian South Medical Journal 21 (1), 19-28, 2018 | 1 | 2018 |
| Life skill training and mental health of employed women AM Khajeian, B Ahmadi, S Nejat, F Kashkooli, A Ansarifar Journal of the Indian Academy of Applied Psychology 41 (1), 159, 2015 | 1 | 2015 |
| An Overview on Causation in Epidemiology H Soori, A AnsariFar, F Mubasheri, A Mahmoudlou, Z Noorafkan, ... Iranian Journal of Epidemiology 7 (4), 73-80, 2012 | 1 | 2012 |
| Mortality and re-fracture rates in low trauma hip fracture V Mohseni, N Fahimfar, A Ansarifar, S Masoumi, M Sanjari, K Khalagi, ... BMC geriatrics 24 (1), 381, 2024 | | 2024 |
| Safety and efficacy of RCP recombinant spike protein covid-19 vaccine compared to Sinopharm BBIBP: A phase III, non-inferiority trial M Solaymani-Dodaran, S Kalantari, SR Banihashemi, A Es-Haghi, ... Heliyon 10 (5), 2024 | | 2024 |
| Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial S Erfanpoor, SR Banihashemi, L Mokhbaeralsafa, S Kalantari, ... BMC medicine 22 (1), 78, 2024 | | 2024 |
| Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18–55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial A Ansarifar, RH Farahani, AK Rahjerdi, M Ahi, A Sheidaei, K Gohari, ... Vaccine: X 15, 100401, 2023 | | 2023 |
| Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial M Solaymani-Dodaran, P Basiri, M Moradi, K Gohari, A Sheidaei, M Ahi, ... Virology Journal 20 (1), 154, 2023 | | 2023 |
| Association of Cardio-Metabolic Risk Factors and Basic and Instrumental Activities of Daily Living Among Elderly People; Bushehr Elderly Health Program K Khalagi, A Ansarifar, N Fahimfar, M Sanjari, S Gharibzdeh, F Sharifi, ... | | 2020 |
